| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXPE | Common Stock | Options Exercise | $2,090,000 | +20,000 | +39% | $104.50 | 71,317 | 21 Dec 2021 | Direct | |
| transaction | EXPE | Common Stock | Sale | $120,477 | -700 | -0.98% | $172.11 | 70,617 | 21 Dec 2021 | Direct | F1, F2 |
| transaction | EXPE | Common Stock | Sale | $919,777 | -5,400 | -7.6% | $170.33 | 65,217 | 21 Dec 2021 | Direct | F1, F3 |
| transaction | EXPE | Common Stock | Sale | $2,384,428 | -13,900 | -21% | $171.54 | 51,317 | 21 Dec 2021 | Direct | F1, F4 |
| transaction | EXPE | Common Stock | Options Exercise | $2,063,770 | +19,749 | +38% | $104.50 | 71,066 | 22 Dec 2021 | Direct | |
| transaction | EXPE | Common Stock | Options Exercise | $26,230 | +251 | +0.35% | $104.50 | 71,317 | 22 Dec 2021 | Direct | |
| transaction | EXPE | Common Stock | Sale | $3,603,398 | -20,000 | -28% | $180.17 | 51,317 | 22 Dec 2021 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXPE | Options to Purchase Common Stock | Options Exercise | $0 | -20,000 | -49% | $0.000000 | 20,502 | 21 Dec 2021 | Common Stock | 20,000 | $104.50 | Direct | F6 |
| transaction | EXPE | Options to Purchase Common Stock | Options Exercise | $0 | -19,749 | -24% | $0.000000 | 61,255 | 22 Dec 2021 | Common Stock | 19,749 | $104.50 | Direct | F7 |
| transaction | EXPE | Options to Purchase Common Stock | Options Exercise | $0 | -251 | -1.2% | $0.000000 | 20,251 | 22 Dec 2021 | Common Stock | 251 | $104.50 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Dzielak on December 6, 2021. |
| F2 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $172.02 to $172.21. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $170.00 to $170.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F4 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $171.02 to $172.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F5 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $180.00 to $180.77. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F6 | Date at which first vesting occurs is indicated. One-half of the total number of options to purchase the Company's common stock vests on the first vesting date and an additional one-half on the fourth anniversary of the date of grant. |
| F7 | Date at which first vesting occurs is indicated. One-fourth of the total number of options to purchase the Company's common stock vests on the first vesting date and an additional one-fourth on each anniversary thereafter until fully vested. |